The Biden administration last month unveiled plans to start offering COVID-19 booster shots to all Americans beginning on Sept. 20. But officials are reportedly now weighing whether this plan will have to be scaled back.
Top health officials are urging the White House to scale back the COVID-19 booster shot plan because more time is needed to review the data, The New York Times reported. CNN also reported that the Biden administration is discussing whether to scale the plan back, citing an official as saying the FDA doesn't currently have enough data to recommend a third dose of the Moderna vaccine. "The officials warned that more time may be needed before enough data is in to recommend boosters for all adults," CNN writes. Data that Moderna recently submitted was "found inadequate and needs strengthening," an official said, NBC News reports.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A White House spokesperson told the Times that "we always said we would follow the science, and this is all part of a process that is now underway." The spokesperson added that when the booster shots received "full review and approval" from the FDA, the administration "will be ready to implement the plan our nation's top doctors developed so that we are staying ahead of this virus."
-
Nepal chooses toddler as its new ‘living goddess’Under the Radar Girls between two and four are typically chosen to live inside the temple as the Kumari – until puberty strikes
-
October 5 editorial cartoonsCartoons Sunday's political cartoons include half-truth hucksters, Capitol lockdown, and more
-
Jaguar Land Rover’s cyber bailoutTalking Point Should the government do more to protect business from the ‘cyber shockwave’?
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
